BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $111,872,886 | -15.0% | 2,964,305 | +2.7% | 0.03% | -15.8% |
| Q2 2023 | $131,545,680 | +17.1% | 2,887,306 | +4.3% | 0.04% | +11.8% |
| Q1 2023 | $112,289,038 | -17.8% | 2,768,467 | +3.3% | 0.03% | -22.7% |
| Q4 2022 | $136,592,474 | -2.5% | 2,679,860 | +3.0% | 0.04% | -12.0% |
| Q3 2022 | $140,164,000 | -13.0% | 2,602,355 | +3.7% | 0.05% | -10.7% |
| Q2 2022 | $161,169,000 | -18.2% | 2,509,238 | -1.2% | 0.06% | -5.1% |
| Q1 2022 | $196,930,000 | -4.8% | 2,539,715 | +5.4% | 0.06% | -3.3% |
| Q4 2021 | $206,930,000 | +10.7% | 2,410,624 | +3.7% | 0.06% | 0.0% |
| Q3 2021 | $186,933,000 | +2.0% | 2,324,157 | +2.1% | 0.06% | 0.0% |
| Q2 2021 | $183,209,000 | -2.2% | 2,275,889 | +2.5% | 0.06% | -11.6% |
| Q1 2021 | $187,261,000 | +3.4% | 2,220,308 | -1.7% | 0.07% | -4.2% |
| Q4 2020 | $181,189,000 | +2.3% | 2,258,079 | +2.5% | 0.07% | -11.1% |
| Q3 2020 | $177,106,000 | -13.6% | 2,202,256 | -7.5% | 0.08% | -19.0% |
| Q2 2020 | $205,022,000 | +14.2% | 2,381,196 | +7.7% | 0.10% | -4.8% |
| Q1 2020 | $179,534,000 | -3.9% | 2,211,271 | -1.0% | 0.10% | +5.0% |
| Q4 2019 | $186,741,000 | -5.3% | 2,233,207 | -1.0% | 0.10% | -13.8% |
| Q3 2019 | $197,242,000 | +11.7% | 2,254,959 | +4.6% | 0.12% | +8.4% |
| Q2 2019 | $176,534,000 | +6.1% | 2,155,475 | +5.3% | 0.11% | 0.0% |
| Q1 2019 | $166,446,000 | +24.8% | 2,047,044 | +1.0% | 0.11% | +4.9% |
| Q4 2018 | $133,394,000 | -10.4% | 2,026,641 | +4.9% | 0.10% | +3.0% |
| Q3 2018 | $148,922,000 | +8.5% | 1,931,782 | +4.0% | 0.10% | -1.0% |
| Q2 2018 | $137,206,000 | -8.6% | 1,858,141 | -19.5% | 0.10% | -14.5% |
| Q1 2018 | $150,154,000 | -13.1% | 2,308,629 | -13.7% | 0.12% | -14.6% |
| Q4 2017 | $172,880,000 | +4.8% | 2,673,665 | +1.7% | 0.14% | -4.9% |
| Q3 2017 | $165,005,000 | +18.1% | 2,629,548 | +13.9% | 0.14% | +9.9% |
| Q2 2017 | $139,764,000 | +69.1% | 2,308,606 | +44.8% | 0.13% | +57.8% |
| Q1 2017 | $82,664,000 | +21.2% | 1,593,978 | +3.7% | 0.08% | +10.7% |
| Q4 2016 | $68,187,000 | -10.6% | 1,537,808 | -4.0% | 0.08% | -16.7% |
| Q3 2016 | $76,239,000 | +0.1% | 1,601,649 | -4.9% | 0.09% | -5.3% |
| Q2 2016 | $76,175,000 | +12.0% | 1,684,538 | +1.7% | 0.10% | +6.7% |
| Q1 2016 | $68,025,000 | -9.9% | 1,655,910 | -16.3% | 0.09% | -12.7% |
| Q4 2015 | $75,504,000 | +25.7% | 1,979,133 | +8.3% | 0.10% | +15.9% |
| Q3 2015 | $60,051,000 | -51.6% | 1,828,028 | +3.0% | 0.09% | -48.5% |
| Q2 2015 | $124,157,000 | +2.8% | 1,775,440 | +0.7% | 0.17% | +0.6% |
| Q1 2015 | $120,787,000 | -1.1% | 1,763,312 | +5.8% | 0.17% | -7.1% |
| Q4 2014 | $122,124,000 | +9.8% | 1,666,309 | +7.5% | 0.18% | 0.0% |
| Q3 2014 | $111,227,000 | +3.3% | 1,549,758 | +4.0% | 0.18% | +1.1% |
| Q2 2014 | $107,714,000 | +2.0% | 1,489,817 | +3.8% | 0.18% | -4.2% |
| Q1 2014 | $105,598,000 | +9.5% | 1,435,133 | +3.5% | 0.19% | +2.7% |
| Q4 2013 | $96,445,000 | +4.6% | 1,386,698 | -1.4% | 0.18% | -2.1% |
| Q3 2013 | $92,212,000 | -3.3% | 1,406,049 | +3.3% | 0.19% | -11.7% |
| Q2 2013 | $95,315,000 | – | 1,360,771 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |